← All companies
CARL
Carlsmed, Inc.
$12.93
+0.34 +2.70%
Key statistics
from XBRL data in SEC filingsMarket cap
$352M
Revenue (TTM)
$56.4M
Net income (TTM)
-$32.6M
EPS (TTM)
$-0.97
P/E ratio
—
Dividend yield
—
Free cash flow
-$29.6M
Cash
$73.0M
Total assets
$119M
Gross margin
75.9%
52-week range
$8.50 – $17.19
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Shareholder vote results
Jun 3, 2026
10-Q
Quarter ended 2026-03-31
May 5, 2026
8-K
Results of operations (earnings release)
May 5, 2026
10-K
Fiscal year ended 2025-12-31
Feb 25, 2026
8-K
Results of operations (earnings release)
Feb 25, 2026
8-K
Results of operations (earnings release)
Jan 12, 2026
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release)
Nov 6, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Oct 30, 2025
10-Q
Quarter ended 2025-06-30
Aug 28, 2025
8-K
Results of operations (earnings release)
Aug 28, 2025
8-K
Amended charter or bylaws; Other events
Jul 24, 2025
Other filings
4
Jun 22, 2026
4
Jun 22, 2026
4
Jun 22, 2026
4
Jun 22, 2026
ARS
Apr 22, 2026
DEFA14A
Apr 22, 2026
DEF 14A
Apr 22, 2026
4
Mar 4, 2026
144
Mar 2, 2026
S-8
Feb 25, 2026
4
Jan 30, 2026
4
Jan 30, 2026
4
Jan 30, 2026
4
Jan 30, 2026
SCHEDULE 13G
Nov 14, 2025
SCHEDULE 13G
Nov 13, 2025
4
Jul 24, 2025
4
Jul 24, 2025
4
Jul 24, 2025
4
Jul 24, 2025
4
Jul 24, 2025
4
Jul 24, 2025
4
Jul 24, 2025
4
Jul 24, 2025
4
Jul 24, 2025
4
Jul 24, 2025
4
Jul 24, 2025
SCHEDULE 13G
Jul 24, 2025